Skip to ContentSkip to Footer

Cyber Attack Hits Merck: Healthcare Prime Target

Merck & Co. said sales of their Keytruda cancer immunotherapy exceeded $1 billion for the first time, but the cost of a cyber attack that temporarily crippled manufacturing and declines in off-patent products caused overall revenue to fall.

 

 

 

 

Read Full Article

 

Get A Quote

This field is for validation purposes and should be left unchanged.

Customer Reviews
5/5

5 stars!

Gail DeLouise-Roth
Gail D
5/5

5 stars!

RF
Robbie F
5/5

5-stars!

Jeffrey Pearson
Jeffrey P
5/5

Five stars!

Marquis Green
Marquis G
5/5

Awesome customer service!

Giselle Cuadrado
Giselle C